- Home
- ANGO vs EDD Comparison
ANGO vs EDD Comparison
Compare ANGO & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- EDD
- Stock Information
- Founded
- ANGO 1988
- EDD 2007
- Country
- ANGO United States
- EDD United States
- Employees
- ANGO N/A
- EDD N/A
- Industry
- ANGO Medical/Dental Instruments
- EDD Finance Companies
- Sector
- ANGO Health Care
- EDD Finance
- Exchange
- ANGO Nasdaq
- EDD Nasdaq
- Market Cap
- ANGO 400.8M
- EDD 329.4M
- IPO Year
- ANGO 2004
- EDD N/A
- Fundamental
- Price
- ANGO $12.02
- EDD $5.31
- Analyst Decision
- ANGO Strong Buy
- EDD
- Analyst Count
- ANGO 3
- EDD 0
- Target Price
- ANGO $19.33
- EDD N/A
- AVG Volume (30 Days)
- ANGO 435.9K
- EDD 254.3K
- Earning Date
- ANGO 10-02-2025
- EDD 01-01-0001
- Dividend Yield
- ANGO N/A
- EDD 7.52%
- EPS Growth
- ANGO N/A
- EDD N/A
- EPS
- ANGO N/A
- EDD N/A
- Revenue
- ANGO $300,718,000.00
- EDD N/A
- Revenue This Year
- ANGO $8.18
- EDD N/A
- Revenue Next Year
- ANGO $5.15
- EDD N/A
- P/E Ratio
- ANGO N/A
- EDD N/A
- Revenue Growth
- ANGO 2.73
- EDD N/A
- 52 Week Low
- ANGO $6.63
- EDD $4.22
- 52 Week High
- ANGO $13.50
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- ANGO 57.09
- EDD 48.24
- Support Level
- ANGO $11.53
- EDD $5.32
- Resistance Level
- ANGO $12.18
- EDD $5.35
- Average True Range (ATR)
- ANGO 0.37
- EDD 0.06
- MACD
- ANGO -0.07
- EDD 0.00
- Stochastic Oscillator
- ANGO 48.62
- EDD 47.05
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.